Targeted Oncology

Acknowledgement to Referees

• Acknowledgement to Referees

EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast

• Open Access
• Commentary

Xiuning Le, Eric Nadler, Daniel B. Costa, John Victor Heymach

Back to the Bench: Unveiling the Tissue Context is Crucial to Enhance the Efficacy of Agnostic Therapies in Oncology

• Commentary

Alessandro Ottaiano, Francesco Sabbatino, Francesco Perri, Marco Cascella, Mariachiara Santorsola, Guglielmo Nasti

Systematic Literature Review of the Prevalence and Prognostic Value of Delta-Like Ligand 3 Protein Expression in Small Cell Lung Cancer

• Open Access
• Systematic Review

Lauren C. Bylsma, Xerxes Pundole, Chia-Hsin Ju, Naushin Hooda, Naimisha Movva, Ehab Elkhouly, Gwyn Bebb, Jon Fryzek, Pablo Martinez, Akhila Balasubramanian, Anne-Marie C. Dingemans

A Systematised Literature Review of Real-World Treatment Patterns and Outcomes in Unresectable Advanced or Metastatic Biliary Tract Cancer

• Open Access
• Review Article

Vivian Peirce, Michael Paskow, Lei Qin, Ruby Dadzie, Maria Rapoport, Samantha Prince, Sukhvinder Johal

A Phase 1b/2 Study of Alpelisib in Combination with Cetuximab in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

• Open Access
• Original Research Article

Albiruni R. Abdul Razak, Hung-Ming Wang, Jang-Yang Chang, Myung-Ju Ahn, Pamela Munster, George Blumenschein Jr, Benjamin Solomon, Darren Wan-Teck Lim, Ruey-Long Hong, David Pfister, Nabil F. Saba, Se-Hoon Lee, Carla van Herpen, Cornelia Quadt, Douglas Bootle, Lars Blumenstein, David Demanse, Jean-Pierre Delord

Efficacy and Safety of Niraparib as First-Line Maintenance Treatment for Patients with Advanced Ovarian Cancer: Real-World Data from a Multicenter Study in China

• Open Access
• Original Research Article

Minmin Zhao, Shanhu Qiu, Xin Wu, Pengcheng Miao, Zhi Jiang, Tao Zhu, Xizhong Xu, Yanling Zhu, Bei Zhang, Donglan Yuan, Yang Zhang, Wei Sun, Aiqin He, Min Zhao, Wenjie Hou, Yingli Zhang, Zhuyan Shao, Meiqun Jia, Mei Li, Jun Chen, Jingcheng Xu, Bingwei Chen, Ying Zhou, Yang Shen

Safety of Subcutaneous Daratumumab in Anti-CD38 Monoclonal Antibody-Naïve Patients with Plasma Cell Disorders: A Multicenter Real-Life Experience

• Open Access
• Original Research Article

Danilo De Novellis, Raffaele Fontana, Salvatore Palmieri, Roberta Della Pepa, Maria Di Perna, Giusy Cetani, Daniela Esposito, Angela Amendola, Giuseppe Delle Cave, Bianca Serio, Denise Morini, Michela Rizzo, Laura Mettivier, Fabio Trastulli, Stefano Rocco, Anastasia Pagano, Serafina Barbato, Aldo Leone, Martina La Magna, Rosario Bianco, Gabriella Rascato, Angela Carobene, Bianca Cuffa, Marialuigia Iannalfo, Valentina Giudice, Gino Svanera, Mario Annunziata, Michele Pizzuti, Ferdinando Frigeri, Catello Califano, Felicetto Ferrara, Fabrizio Pane, Carmine Selleri

Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma

• Original Research Article

Alexandr Poprach, Igor Kiss, Michal Stanik, Tamara Barusova, Lenka Pospisilova, Ondrej Fiala, Jindrich Kopecky, Igor Richter, Bohuslav Melichar, Hana Studentova, Radek Lakomy, Milos Holanek, Aneta Rozsypalova, Anezka Zemanková, Marek Svoboda, Tomas Buchler

Clinical Characteristics of Patients with Advanced ALK-Translocated Non-small Cell Lung Cancers and Long-Term Responses to Crizotinib (CRIZOLONG GFPC 05-19 Study)

• Original Research Article

Estelle Dhamelincourt, Renaud Descourt, Gaelle Rousseau-Bussac, Hélène Doubre, Chantal Decroisette, Pierre Demontrond, Gwenaelle Le Garff, Lionel Falchero, Eric Huchot, Sabine Vieillot, Romain Corre, Laure Kazulinski, Acya Bizieux, Laurence Bigay-Gamé, Hugues Morel, Olivier Molinier, Christos Chouaïd, Florian Guisier

Chemoimmunotherapy Versus Pembrolizumab as a First-Line Treatment for Patients with Advanced Non-small Cell Lung Cancer and High PD-L1 Expression: Focus on the Role of Performance Status

• Original Research Article

Kenji Morimoto, Tadaaki Yamada, Hayato Kawachi, Motohiro Tamiya, Yoshiki Negi, Yasuhiro Goto, Akira Nakao, Shinsuke Shiotsu, Keiko Tanimura, Takayuki Takeda, Asuka Okada, Taishi Harada, Koji Date, Yusuke Chihara, Isao Hasegawa, Nobuyo Tamiya, Naoya Nishioka, Yuki Katayama, Masahiro Iwasaku, Shinsaku Tokuda, Takashi Kijima, Koichi Takayama

Histo-Molecular Factors of Response to Combined Chemotherapy and Immunotherapy in Non-Small Cell Lung Cancers

• Open Access
• Original Research Article

Marine Marchal, Vincent Leroy, Hélène Behal, Eric Dansin, Nicolas Paris, Soraya Bordier, Sarah Humez, Fabienne Escande, Clément Gauvain, Alexis B. Cortot

Dual PI3K/HDAC Inhibitor BEBT-908 Exhibits Potent Efficacy as Monotherapy for Primary Central Nervous System Lymphoma

• Original Research Article

Ning Wang, Zhenxian Mo, Lu Pan, Minhua Zhou, Xiaolan Ye, Xinjian Liu, Xiong Cai, Changgeng Qian, Feili Chen, Yan Xiong, Fushun Fan, Wenyu Li

Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators

• Open Access
• Original Research Article

Francesco Volta, Silvia La Monica, Alessandro Leonetti, Letizia Gnetti, Mara Bonelli, Andrea Cavazzoni, Claudia Fumarola, Maricla Galetti, Kamal Eltayeb, Roberta Minari, Pier Giorgio Petronini, Marcello Tiseo, Roberta Alfieri

Durvalumab: A Review in Advanced Biliary Tract Cancer

• Open Access
• Adis Drug Evaluation

Simon Fung, Yahiya Y. Syed

Ivosidenib: A Review in Advanced Cholangiocarcinoma

• Open Access
• Adis Drug Evaluation

James E. Frampton

Trastuzumab Deruxtecan: A Review in Gastric or Gastro-Oesophageal Junction Adenocarcinoma

• Adis Drug Evaluation

Connie Kang

Correction to: EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast

• Open Access
• Correction

Xiuning Le, Eric Nadler, Daniel B. Costa, John Victor Heymach